Study: A-Fib Linked to Increased Risk of Dementia
According to a new study, there may be a link to atrial fibrillation and its association with an increased risk of patients suffering from dementia. In a study conducted by...
Dr. Pullen Questions Multaq’s Role in Treating Atrial Fibrillation
In a medical blog, Dr. Pullen is questioning Multaq’s role in treating atrial fibrillation. With all of the bad news surrounding the drug’s dangerous and potentially life-threatening side effects, the...
FDA Advisory Panel Recommends Xarelto for Stroke Prevention
An FDA advisory panel has decided to recommend Xarelto (rivaroxaban) for approval in preventing strokes and blood clots in patients who are suffering from atrial fibrillation. Xarelto was deemed as...
New “Hybrid” Procedure Can Treat A-fib Patients
A new “hybrid” procedure that is only available at a small group of medical centers may prove to be a better alternative for patients suffering from atrial fibrillation (a-fib). The...
Is There a Safe Generic Alternative to Multaq?
Treatments for atrial fibrillation (a-fib) certainly can be beneficial to those who suffer from the condition; however, with all of the controversy surrounding the side effects of Multaq (dronedarone), it’s...